Your browser doesn't support javascript.
loading
A multicenter study analyzing the association of vitamin D deficiency and replacement with infectious outcomes in patients with burn injuries.
Garner, Katelyn M; Zavala, Sarah; Pape, Kate O; Walroth, Todd; Reger, Melissa; Thomas, Wendy; Hoyte, Brittany; Adams, Beatrice; Hill, David M.
Affiliation
  • Garner KM; Clinical Pharmacist, Department of Pharmacy, Regional One Health, 877 Jefferson Avenue, Memphis, TN 38103, USA.
  • Zavala S; Clinical Pharmacist, Department of Pharmacy, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.
  • Pape KO; Clinical Pharmacist, Department of Pharmacy, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, IA 52242, USA.
  • Walroth T; Clinical Pharmacist, Department of Pharmacy Services, Eskenazi Health, 640 Eskenazi Avenue, Indianapolis, IN 46202, USA.
  • Reger M; Clinical Pharmacist, Pharmacy Department, Community Regional Medical Center, 2823 Fresno Street, Fresno, CA 93721, USA.
  • Thomas W; Clinical Pharmacist, Pharmacy Department, Spectrum Health, 100 Michigan Street Northeast, Grand Rapids, MI 49503, USA.
  • Hoyte B; Clinical Pharmacist, Pharmacy Department, Spectrum Health, 100 Michigan Street Northeast, Grand Rapids, MI 49503, USA.
  • Adams B; Clinical Pharmacist, Pharmacy Department, Tampa General Hospital, 1 Tampa Circle, Tampa, FL 33606, USA.
  • Hill DM; Clinical Pharmacist, Department of Pharmacy, Regional One Health, 877 Jefferson Avenue, Memphis, TN 38103, USA. Electronic address: dmhill@regionalonehealth.org.
Burns ; 48(6): 1319-1324, 2022 09.
Article in En | MEDLINE | ID: mdl-34903417
ABSTRACT
Vitamin D (25OHD) deficiency is associated with poor outcomes in intensive care populations. The primary objective of this 7-center study was to determine if 25OHD deficiency is associated with infectious outcomes in adult burn patients. Generalized linear mixed modeling was used to control for center effect, percent total body surface area burn (% TBSA), age, and presence of inhalation injury. A total of 1147 patients were initially included (admitted January 2016 through August 2019). After exclusions, 234 (56.8%) in the deficient (25OHD<20 ng/mL) and 178 in the non-deficient group (25OHD ≥ 20 ng/mL) remained, surpassing a priori power requirements. The non-deficient group had their concentration drawn earlier (p < 0.001), were more likely to be male (p = 0.006), Caucasian (p < 0.001), have lower body mass index (p = 0.009), lower % TBSA (p = 0.002), and taking a 25OHD supplement prior to admission (p < 0.001). Deficient patients were more likely to have an infectious outcome (52.1% vs 36.0%, p = 0.002), acute kidney injury with renal replacement therapy (p = 0.009), less ventilator free days in the first 28 days (p < 0.001), and vasopressors (p = 0.01). After controlling for center, % TBSA, age, and inhalation injury the best model also included presence of deficiency (OR 2.425 [CI 1.206-4.876]), days until 25OHD supplement initiation (OR 1.139 [CI 1.035-1.252]), and choice of cholecalciferol over ergocalciferol (OR 2.112 [CI 1.151-3.877]). To the authors' knowledge, this is the first multicenter study to evaluate the relationship between 25OHD and infectious complications in burn patients.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Vitamin D Deficiency / Burns Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Vitamin D Deficiency / Burns Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Year: 2022 Type: Article